ADMA Biologics Announces Pricing of Public Offering of Common Stock
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/11/2026
- Wall St set to gain on tech rebound, Middle East in focus
- Oracle results beat estimates, but shares fall on plans for $40 billion raise
- Oil drops as Trump cancels planned strikes against Iran
- Intel rallies as BofA double-upgrades stock on increased CPU, foundry visibility
- Oppenheimer sees little strategic case for Tesla-SpaceX merger
- Needham Starts Hyliion Holdings (HYLN) at Buy
- Adobe CFO Dan Durn to depart company in June 2026
- Oppenheimer Starts SpaceX (SPCX) at Outperform, PT $190, 'space infrastructure appears structurally advantaged'
- Pentagon reportedly locked down, hazmat teams responding
- Alibaba falls on China AI capex report; Citi says selloff is premature
Adma Biologics (ADMA) Prices 1.23M Common Offering for Proceeds of $9.8M
March 13, 2015 9:22 AM EDTAdma Biologics (NASDAQ: ADMA) announced the pricing of its previously announced underwritten public offering of 1,225,000 shares of common stock at a public offering price of $8.00 per share, resulting in gross proceeds of approximately $9,800,000.
The offering is expected to close on March 18, 2015, subject to the... More
